WWTR1 and cancer: Numerous studies have demonstrated that high expression and/or nuclear localization of YAP/TAZ in cancer cells are correlated with poor clinical outcomes in many cancer types such as lung, colorectal, breast, liver, gastric, pancreatic, prostate, endometrial, esophageal, bladder, and ovarian cancer (4, 46, 47).